JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB227130

Anti-PUMA antibody - C-terminal

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal PUMA antibody. C-terminal. Suitable for IP, WB, IHC-P and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human BBC3.

View Alternative Names

PUMA, BBC3, JFY-1, p53 up-regulated modulator of apoptosis

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PUMA antibody - C-terminal (AB227130)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PUMA antibody - C-terminal (AB227130)

Paraffin-embedded human hepatoma tissue tissue stained for PUMA using ab227130 at 1/500 dilution in immunohistochemical analysis.

Immunoprecipitation - Anti-PUMA antibody - C-terminal (AB227130)
  • IP

Supplier Data

Immunoprecipitation - Anti-PUMA antibody - C-terminal (AB227130)

PUMA was immunoprecipitated from HCT 116 (human colorectal carcinoma cell line) treated with 30 μM cisplatin for 24 hours, whole cell extract with 4 μg of ab227130. Western blot was performed from the immunoprecipitate using ab227130. Anti-rabbit IgG was used as a secondary reagent.

Lane 1 : Preimmune Rabbit IgG instead of ab227130 in HCT 116 treated with 30 μM cisplatin for 24 hours, whole cell extract.

Lane 2 : ab227130 IP in HCT 116 treated with 30 μM cisplatin for 24 hours, whole cell extract.

15 % SDS-PAGE gel.

All lanes:

Immunoprecipitation - Anti-PUMA antibody - C-terminal (ab227130)

Predicted band size: 21 kDa

false

Western blot - Anti-PUMA antibody - C-terminal (AB227130)
  • WB

Supplier Data

Western blot - Anti-PUMA antibody - C-terminal (AB227130)

12 % SDS-PAGE gel.

All lanes:

Western blot - Anti-PUMA antibody - C-terminal (ab227130) at 1/500 dilution

Lane 1:

K562 (human chronic myelogenous leukemia cell line from bone marrow) whole cell extract at 30 µg

Lane 2:

THP-1 (human monocytic leukemia cell line) whole cell extract at 30 µg

Predicted band size: 21 kDa

false

Western blot - Anti-PUMA antibody - C-terminal (AB227130)
  • WB

Supplier Data

Western blot - Anti-PUMA antibody - C-terminal (AB227130)

15% SDS-PAGE gel.

All lanes:

Western blot - Anti-PUMA antibody - C-terminal (ab227130) at 1/1000 dilution

Lane 1:

HCT 116 (human colorectal carcinoma cell line) with mock treatment for 0 hours, whole cell lysate at 30 µg

Lane 2:

HCT 116 (human colorectal carcinoma cell line) with 30 uM cisplatin treatment for 24 hours, whole cell lysate at 30 µg

Predicted band size: 21 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IP, IHC-P

applications

Immunogen

Synthetic Peptide within Human BBC3. The exact immunogen used to generate this antibody is proprietary information.

Q9BXH1

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/100 - 1/500", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/1000", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7 Preservative: 0.01% Thimerosal (merthiolate) Constituents: 10% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PUMA also known as BBC3 (Bcl-2-binding component-3) is a pro-apoptotic protein that plays important mechanical roles in promoting apoptosis. It has a mass of approximately 23 kDa. PUMA is expressed widely in various tissues including the lung liver and heart. The protein works mechanically by interacting with anti-apoptotic Bcl-2 family members releasing pro-apoptotic factors like Bax and Bak which engage mitochondria to trigger cell death.
Biological function summary

PUMA functions as a pivotal mediator of apoptosis in response to diverse stimuli such as DNA damage and oncogenic stress. As part of the Bcl-2 family PUMA does not typically form a complex with other proteins but functions directly by binding and neutralizing anti-apoptotic Bcl-2 family proteins. This action results in the release of caspase-activating factors from mitochondria essential for programmed cell death.

Pathways

Several cellular pathways incorporate PUMA to regulate apoptosis. PUMA is notably included in the p53 pathway where p53 transcriptionally activates PUMA following cellular stress or DNA damage. The presence of related proteins like Bax and Bim in the mitochondrial apoptotic pathway links these signals to the mitochondrial death machinery facilitating apoptosis.

PUMA plays significant roles in cancer and neurodegenerative conditions. PUMA overexpression induces excessive cell death relevant in the pathology of neurodegenerative diseases. In cancer PUMA's interactions with proteins like p53 highlight its involvement in tumor suppression suggesting that dysregulation of PUMA expression can contribute to tumorigenesis when anti-apoptotic signals predominate potentially leading to chemoresistance.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Essential mediator of p53/TP53-dependent and p53/TP53-independent apoptosis (PubMed : 11463391, PubMed : 23340338). Promotes partial unfolding of BCL2L1 and dissociation of BCL2L1 from p53/TP53, releasing the bound p53/TP53 to induce apoptosis (PubMed : 23340338). Regulates ER stress-induced neuronal apoptosis (By similarity).
See full target information BBC3

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Experimental and therapeutic medicine 20:1169-1175 PubMed32742355

2020

MicroRNA-425 inhibits proliferation of chronic lymphocytic leukaemia cells through regulation of the Bruton's tyrosine kinase/phospholipase Cγ2 signalling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jianying Chen,Yuhua Li,Xiaoling Xie
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com